PD-1/PD-L1-IN-54
Product Specifications
UNSPSC Description
PD-1/PD-L1-IN-54 (Compound 6) is a moderately affinic PD-1/PD-L1 inhibitor (KD: PD-1, 55.8 μM; PD-L1, 46.4 μM; IC50: 88.6 μM). PD-1/PD-L1-IN-54 inhibits PD-1/PD-L1 interactions and shows anticancer activity by activating CD8+ T cells, upregulating PD-1 expression, and increasing secretion of IFN-γ and IL-2. PD-1/PD-L1-IN-54 inhibits cancer cell proliferation and promotes apoptosis. PD-1/PD-L1-IN-54 also regulates T cell immunity through the PI3K/Akt pathway correlated with PD-1/PD-L1[1].
Target Antigen
Akt; IFNAR; Interleukin Related; PD-1/PD-L1; PI3K
Type
Reference compound
Related Pathways
Immunology/Inflammation;PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-1-pd-l1-in-54.html
Smiles
COC1=CC(O)=C(C(OC)=O)C(OC2=C(C)C=C(O)C=C2OC)=C1Cl
Molecular Weight
368.77
References & Citations
[1]Kuang QX, et al. New benzophenone analogs from Nigrospora sphaerica and their inhibitory activity against PD-1/PD-L1 interactions. Bioorganic chemistry, 2024, 153, 107899.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-159892/PD-1-PD-L1-IN-54-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-159892/
Clinical Information
No Development Reported
CAS Number
1393644-68-2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items